Lesley J Scott1, Victoria J Muir. Show Affiliations » 1. Adis, a Wolters Kluwer Business, Auckland, New Zealand. demail@adis.co.nz
Abstract
Entities: Chemical Disease Species
Mesh: See more » Antibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/pharmacokineticsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/pharmacokineticsAntineoplastic Agents/therapeutic useBone Neoplasms/prevention & controlBone Neoplasms/secondaryClinical Trials as TopicDenosumabHumansRANK Ligand/antagonists & inhibitors
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsRANK LigandDenosumab
Year: 2011 PMID: 22050342 DOI: 10.2165/11207650-000000000-00000
Source DB: PubMed Journal: BioDrugs ISSN: 1173-8804 Impact factor: 5.807